Table 3 Characteristics of control patients who were anti-HCV+/HCV-RNA negative at incarceration and during follow-up of 6 months.
From: Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Subject # | Age (Years) | Risk factor | Duration of IVDU (months) | Peak ALT (U/L) | Anti-HCV-antibodies ELISA | HCV-RNA |
|---|---|---|---|---|---|---|
15 | 22 | Unsafe sex | n.a. | 19 | Positive | Negative |
30 | 22 | n.a. | n.a. | 11 | Positive | Negative |
35 | 20 | IVDU | 24 | 29 | Positive | Negative |
40 | 20 | n.a. | n.a. | 11 | Positive | Negative |
50 | 21 | IVDU | 24 | 10 | Positive | Negative |
59 | 20 | n.a. | n.a.- | 6 | Positive | Negative |
60 | 19 | IVDU | 10 | 55 | Positive | Negative |
71 | 21 | IVDU | 2 | 16 | Positive | Negative |
94 | 21 | IVDU | 24 | 321 | Positive | Negative |